TY - JOUR
T1 - P450-humanized and human liver chimeric mouse models for studying xenobiotic metabolism and toxicity
AU - Bissig, Karl Dimiter
AU - Han, Weiguo
AU - Barzi, Mercedes
AU - Kovalchuk, Nataliia
AU - Ding, Liang
AU - Fan, Xiaoyu
AU - Pankowicz, Francis P.
AU - Zhang, Qing Yu
AU - Ding, Xinxin
N1 - Funding Information:
Q.-Y.Z. and X.D. are supported in part by the National Institutes of Health (NIH) [Grants CA092596, ES020867, and GM082978]. K.-D.B. is supported by the NIH [Grants HL134510 and DK115461] and the Texas Hepatocellular Carcinoma Consortium (THCCC) (CPRIT #RP150587). K.-D.B., M.B., F.P.P. have a financial interest in Avachrome Inc. No other potential conflicts of interest relevant to this article are reported.
Funding Information:
Q.-Y.Z. and X.D. are supported in part by the National Institutes of Health (NIH) [Grants CA092596, ES020867, and GM082978]. K.-D.B. is supported by the NIH [Grants HL134510 and DK115461] and the Texas Hepatocellular Carcinoma Consortium (THCCC) (CPRIT #RP150587). K.-D.B., M.B., F.P.P. have a financial interest in Avachrome Inc. No other potential conflicts of interest relevant to this article are reported. https://doi.org/10.1124/dmd.118.083303.
Publisher Copyright:
© 2018 by The American Society for Pharmacology and Experimental Therapeutics.
PY - 2018/11
Y1 - 2018/11
N2 - Preclinical evaluation of drug candidates in experimental animal models is an essential step in drug development. Humanized mouse models have emerged as a promising alternative to traditional animal models. The purpose of this mini-review is to provide a brief survey of currently available mouse models for studying human xenobiotic metabolism. Here, we describe both genetic humanization and human liver chimeric mouse models, focusing on the advantages and limitations while outlining their key features and applications. Although this field of biomedical science is relatively young, these humanized mouse models have the potential to transform preclinical drug testing and eventually lead to a more cost-effective and rapid development of new therapies.
AB - Preclinical evaluation of drug candidates in experimental animal models is an essential step in drug development. Humanized mouse models have emerged as a promising alternative to traditional animal models. The purpose of this mini-review is to provide a brief survey of currently available mouse models for studying human xenobiotic metabolism. Here, we describe both genetic humanization and human liver chimeric mouse models, focusing on the advantages and limitations while outlining their key features and applications. Although this field of biomedical science is relatively young, these humanized mouse models have the potential to transform preclinical drug testing and eventually lead to a more cost-effective and rapid development of new therapies.
UR - http://www.scopus.com/inward/record.url?scp=85055075476&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055075476&partnerID=8YFLogxK
U2 - 10.1124/dmd.118.083303
DO - 10.1124/dmd.118.083303
M3 - Review article
C2 - 30093418
AN - SCOPUS:85055075476
SN - 0090-9556
VL - 46
SP - 1734
EP - 1744
JO - Drug Metabolism and Disposition
JF - Drug Metabolism and Disposition
IS - 11
ER -